Wockhardt rose 3.54% to Rs 432 at 9:24 IST on BSE, with the stock extending Thursday's 9.6% rally triggered by the company's announcement of listing its Swiss arm on the Berne Stock Exchange in Switzerland on Thursday, 19 December 2013.
Meanwhile, the S&P BSE Sensex was up 47.43 points or 0.23% at 20,756.05.
On BSE, so far 1.65 lakh shares were traded in the counter as against average daily volume of 6.81 lakh shares in the past two weeks.
The stock hit a high of Rs 433.80 and a low of Rs 421 so far during the day.
Shares of Wockhardt have rallied 13.47% in two trading sessions from Rs 380.70 on 18 December 2013 after the company before market hours on Thursday, 19 December 2013 said that its Swiss arm will list on the Berne Stock Exchange in Switzerland on Thursday, 19 December 2013. The stock had rallied 9.6% to settle at Rs 417.25 on Thursday, 19 December 2013.
Wockhardt's Swiss arm, Wockhardt Bio AG, had offered 23.48 lakh ordinary shares of Swiss Franc (CHF) 1 each, representing 5% of the post diluted capital, for subscription at a price of CHF 5.05 per ordinary share in its initial public offering (IPO).
The ordinary shares of Wockhardt Bio AG are scheduled to be listed on 19 December 2013 on the Berne Stock Exchange in Switzerland.
Wockhardt Bio AG is the holding company for the pharmaceutical and biotech firm's international operations. Close to 75% of Wockhardt's business comes from outside India and some of the major geographies where it is present include the US, the UK, Ireland and France.
On a consolidated basis, Wockhardt's net profit fell 69.5% to Rs 138.50 crore on 11.2% decline in net sales to Rs 1196.97 crore in Q2 September 2013 over Q2 September 2012.
Wockhardt is a high-technology intensive global pharmaceutical and biotechnology company with multi-disciplinary and innovative R&D programmes. It has three research centres globally and manufacturing facilities across India, USA, UK and Ireland. The company has a significant presence in USA, Europe and India.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
